Pathogen-specific CD8 T cell responses are directly inhibited by IL-10

Journal of Immunology

Volumn 179, Issue 7, 2007, Pages 4520-4528

  Biswas, Partha Sarathi ^a   Pedicord, Virginia ^a   Ploss, Alexander ^b   Menet, Ewa ^a   Leiner, Ingrid ^a   Pamer, Eric G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LISTERIOSIS; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION;

EID: 41549114751     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.7.4520     Document Type: Article

References (35)

1. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
2. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
3. Joss, A., M. Akdis, A. Faith, K. Blaser, and C. A. Akdis. 2000. IL10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30: 1683-1690.
4. Taga, K., J. Chretien, B. Cherney, L. Diaz, M. Brown, and G. Tosato. 1994. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J. Clin. Invest. 94: 251-260.
5. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood 81: 2964-2971.
6. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J. Immunol. 150: 4754-4765.
7. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148: 1143-1148.
8. MacNeil, I. A., T. Suda, K. W. Moore, T. R. Mosmann, and A. Zlotnik. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145: 4167-4173.
9. Fiorentino, D. F., A. Zlotnik, T. R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815-3822.
10. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451.
11. + T cell primary responses and inhibition of secondary responses. J. Immunol. 174: 5382-5389.
12. - Th1 cells are the major source of host-protective regulatory IL10 during intracellular protozoan infection. J. Exp. Med. 204: 273-283.
13. - Th1 cells are the source of IL10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297.
14. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
15. Lara-Tejero, M., and E. G. Pamer. 2004. T cell responses to Listeria monocytogenes. Curr. Opin. Microbiol. 7: 45-50.
16. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
17. + T cell contraction is controlled by early inflammation. Nat. Immunol. 5: 809-817.
18. + T cell response. Immunity 25: 19-29.
19. Busch, D. H., K. M. Kerksiek, and E. G. Pamer. 2000. Differing roles of inflammation and antigen in T cell proliferation and memory generation. J. Immunol. 164: 4063-4070.
20. + memory T cells. Nature 441: 890-893.
21. Kelly, J. P., and G. J. Bancroft. 1996. Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur. J. Immunol. 26: 356-364.
22. Dai, W. J., G. Kohler, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol. 158: 2259-2267.
23. Pasche, B., S. Kalaydjiev, T. J. Franz, E. Kremmer, V. Gailus-Durner, H. Fuchs, M. Hrabe de Angelis, A. Lengeling, and D. H. Busch. 2005. Sex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 production. Infect. Immun. 73: 5952-5960.
24. Carrero, J. A., B. Calderon, and E. R. Unanue. 2006. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203: 933-940.
25. Foulds, K. E., M. J. Rotte, and R. A. Seder. 2006. IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection. J. Immunol. 177: 2565-2574.
26. Flesch, I. E., and S. H. Kaufmann. 1994. Role of macrophages and αβ T lymphocytes in early interleukin 10 production during Listeria monocytogenes infection. Int. Immunol. 6: 463-468.
27. Liu, Y., S. H. Wei, A. S. Ho, R. de Waal Malefyt, and K. W. Moore. 1994. Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152: 1821-1829.
28. Spencer, S. D., F. Di Marco, J. Hooley, S. Pitts-Meek, M. Bauer, A. M. Ryan, B. Sordat, V. C. Gibbs, and M. Aguet. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187: 571-578.
29. Havenar-Daughton, C., G. A. Kolumam, and K. Murali-Krishna. 2006. Cutting edge: the direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176: 3315-3319.
30. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
31. + T cell responses. J. Immunol. 175: 5624-5628.
32. + T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
33. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
34. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472.
35. + cells produce TGF-β that can suppress HCV-specific T cell responses. J. Virol. 81: 5882-5892.